Hamilton-based McMaster start-up secures $140M (CAD) to commercialize potential cancer treatment
In 2018, Fusion Pharmaceuticals was recognized as Ontario’s Life Sciences Company of the Year. John, who graduated with a Ph.D. in Chemistry from McMaster in 1997, received the Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering from NSERC in 2015.
“It is McMaster’s unique approach and commitment to research excellence that allowed Dr. Valliant to take new paths, investigate uncharted territory and train incredibly talented teams of students – our next generation of leaders,” Associate Vice-President Research Karen Mossman wrote in the Hamilton Spectator.
Read more about Fusion Pharmaceuticals at McMaster Daily News.
Related News
News Listing
Anika Kina Kudaka breaks the echo chamber and finds her own path
Careers & Experience, Co-op, Community
Origin story – Biology professor proud to lead one of Canada’s oldest cultural organizations
Community, Faculty, Origin stories, Uncategorized
“When we have privilege, blessings and skills, it’s our responsibility to better the lives of others” – McMaster WISE adds community service to its mission
Community, Graduate students, Outreach